Blockchain Registration Transaction Record
Nutriband's AVERSA Fentanyl Patch Leads Abuse-Deterrent Innovation
Nutriband Inc. reports a 63% revenue increase and advances its AVERSA Fentanyl patch, aiming to revolutionize abuse-deterrent opioid treatments. Explore the impact.

Nutriband's development of the AVERSA(TM) Fentanyl patch represents a critical advancement in addressing the opioid crisis by offering a safer, abuse-deterrent option. This innovation could significantly reduce the potential for misuse of fentanyl patches, a pressing public health issue. The company's financial growth and strategic initiatives highlight its potential to make a meaningful impact in the pharmaceutical industry and beyond.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x73203f50b0a5c747066eadc941f5673d94d16f615fb015b339601875cb9f5c65 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fastWntO-8ea8dbbe9701765674d9a8de56be6771 |